Included In This Lesson
Outline
What is the generic name?
SUTIMLIMAB-JOME
What is the Trade Name for SUTIMLIMAB-JOME?
Enjaymo
What are the Indications for SUTIMLIMAB-JOME?
- 1 INDICATIONS AND USAGE ENJAYMO is a classical complement inhibitor indicated to decrease the need for red blood cell (RBC) transfusion due to hemolysis in adults with cold agglutinin disease (CAD). ( 1 ) Cold Agglutinin Disease ENJAYMO (sutimlimab-jome) is indicated to decrease the need for red blood cell (RBC) transfusion due to hemolysis in adults with cold agglutinin disease (CAD).
View Our Nursing Pharmacology Course
References: https://open.fda.gov/
Other Pharm Resources